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Concern about the rising asthma mortality and morbidity in several countries in the 1980s and the 
consequent development of international guidelines for diagnosis and management of asthma, gave 
reason to evaluate national mortality and hospital admission data from the Netherlands for asthma 
[International Classification of Diseases (ICD) 4931 over the period 1980-94, as well as for chronic 
obstructive pulmonary disease (COPD) (ICD 490-2,496) and acute bronchi(oli)tis (ICD 466), according 
to age (O-4, 5-34, 35-64 and 2 65 years). Rates per million population per year were calculated and time 
trend analyses were performed. 
Hospital admissions for asthma showed a decrease in all age groups except in age group O-4 years. In 
this age group, an increase was found which continued in the 1990s. Hospital admissions also increased 
for COPD and acute bronchi(oli)tis in the age group O-4 years. These increases, however, had no impact 
on the respiratory mortality, which remained stable and even fell for acute bronchi(oli)tis. Asthma 
mortality showed a large decline in the 1990s in age group 265 years in both sexes, and also fell, to a 
lesser extent, in age group 35-64 years. In both age groups, rising COPD trends were found in hospital 
admissions and mortality, except in males aged 35-64 years, in whom trends fell in the last decade. In age 
group 5-34 years, asthma mortality declined over the whole study period, whilst the other respiratory 
trends were stable. 
It is concluded that asthma statistics in the Netherlands indicate favourable development, except for 
the age group 04 years. In this age group, morbidity from asthma and from other reactive airway 
disorders is still of great concern. 
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Introduction 
The reported rise in the mortality and morbidity of 
asthma in the 1980s in various countries (l-3) and 
the consequent concern about the adequacy of the 
treatment of the asthmatic patient (4), prompted 
the development of guidelines for diagnosis and 
management of asthma (5-7). Together with exten- 
sive research on the different aspects of asthma in the 
last decades, it may be expected that these factors 
have had an impact on actual treatment strategies 
and, consequently, on asthma statistics. 
In the Netherlands, national mortality data and 
hospital admission data are available on a year-to- 
year basis, as are population statistics. The present 
study presents trends on asthma mortality and 
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hospital admissions in the Netherlands over the 
period 1980-94, in which the same revision of the 
International Classification of Diseases (ICD) was in 
operation. 
As it is often difficult to distinguish between asthma 
and other obstructive respiratory diseases with 
asthma-like symptoms, especially in the very young 
and the elderly @-lo), these latter diseases were also 
included in the analysis. This is important as it is 
thought that even in the age group 5-34 years, in 
which asthma mortality rates are probably most 
reliable, a labelling shift from acute bronchitis to 
asthma may have been a contributing factor to the 
observed rise in asthma mortality in the U.K. in this 
age group (11). 
Materials and Methods 
Annual national crude mortality data were obtained 
by gender, age and primary cause of death, based 
on the ninth revision of the ICD in 1979, from 
the Netherlands Central Bureau of Statistics (12). 
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TABLE 1. Trend in mortality from asthma, acute bronchi(oli)tis and chronic obstructive 
pulmonary disease (COPD) in the O-4 and 5-34 years age groups (males+females) in the 
period 1980-94 
Rate per lo6 










4.5 4.1 +0.03 0.09 0.695 
3-l 1.1 - 0.14 0.03 0.002 
16.9 1.0 - 0.79 0.18 0.00 1 
o-05* 0.0 - - 
2.3 1.0 +0.04 0.10 0.730 
0.7 0.8 - 0.01 0.03 0.672 
*Code 493, tCode 466 and ICode 490, 491, 492 and 496, International Classification of 
Diseases (ICD-9). 
§Linear regression analysis was not carried out because a total of only six persons died 
from acute bronchitis over the 15-yr period in a annual population of 6.5-7 million. 
Likewise, hospital morbidity data based on the diag- 
nosis of discharge (ICD-9 clinical modification) were 
obtained from the Dutch Centre for Health Care 
Information. These data covered, on average, 98.3% 
(range 9499.7%) of all hospital admissions in the 
Netherlands in the period under study, having been 
adjusted to 100% (13). 
Four major age groups were considered: O-4, 5-34, 
35-64 and 265 years. The following ICD codes were 
analysed: ICD 493, asthma; ICD 490, bronchitis 
not specified as acute or chronic; ICD 491, chronic 
bronchitis; ICD 492, emphysema; ICD 496, chronic 
obstructive airway disease not classified elsewhere; 
and ICD 466, acute bronchi(oli)tis in the age groups 
04 and 5-34 years alone. ICD 490, ICD 491, ICD 
492 and ICD 496 are combined and referred to as 
chronic obstructive pulmonary disease (COPD). 
acute bronchi(oli)tis and COPD, with the slope of the 
regression, its standard error (SE) and P value over 
the period 1980-94. Data for males and females are 
not presented separately because of the small actual 
numbers. With respect to asthma, a significant 
decrease was found in the mortality rate in the 5-34 
years age group, occurring over the whole study 
period as illustrated in Fig. 1. As for acute bronchi- 
(oli)tis, a significant decrease was found in the O-4 
years age group, the rate dropping to about the same 
level as the rate for asthma in this age group, which 
fluctuated over the study period between 0 and 4.5 
persons per million. 
In Fig. 2, the trends in asthma mortality rate in the 
age groups 35-64 and 2 65 years are shown for males 
Rates per million population were calculated per 
calendar year for the four age groups, using the 
annual mean population age-structure (14). In the 
Netherlands, population size increased steadily from 
14.1 million in 1980 to 15.4 million in 1994, but 
changes were unevenly distributed among the ages. 
Time trend analyses on the rates were performed by 
means of least squares regression. 
Results 
MORTALITY Year 
Table 1 presents the mortality rates in the age groups FIG. 1. Mortality from asthma (ICD 493) in the 
O-4 and 5-34 years in 1980 and 1994 for asthma, 5-34 years age group in the period 1980-94. 
ASTHMA STATISTICS 419 
250, 
E2 1 “““““‘l’ 
80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 
Year 
FIG. 2. Mortality from asthma (ICD 493) in age 
groups 35-64 and 265 years by gender in the 
period 1980-94 (log scale). Age group 35-64 years, 
-m-; 265 years, -O-; males, ---; females, - - -. 
Males 35-64 years, slope (SE) - 0.6 (0.2), P=O.O02; 
females 35-64 years, slope (SE) - 0.4 (0.2), 
P=O.O29. 
and females separately. There was a slight but signifi- 
cant decrease in mortality from asthma in both males 
and females aged 35-64 years. In the 265 years age 
group, linear regression analysis was not carried out 
because of the large decline in mortality observed 
in the early 1990s. Figure 3 shows the trends in 
mortality rate for COPD in these age groups when 
the rate in 1980 is set to 100. All trends showed a 
significant increase apart from the significant decrease 
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FIG. 3. Mortality from chronic obstructive pulmo- 
nary disease (ICD 490-2, 496) in age groups 35-64 
and 265 years by gender in the period 1980-94, 
rates per million population in 1980= 100. Age 
group 35-64 years, -O-; 265 years, -0-; males, ’ 
---; females, - - -. Males 35-64 years, slope (SE) 
- 3.5 (0.5); females 35-64 years, slope (SE) + 1.6 
(0.3); males 265 years, slope (SE) +97.5 (20.2); 
females 265 years, slope (SE) +63.5 (4.8); all 
P<O.OOl. 
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FIG. 4. Hospital admissions for asthma (ICD 493) 
by age group in the period 1980-94, rates per 
million population in 1980= 100. Age group 04 
years, -+-; 5-34 years, -A-; 35-64 years, -a-; 
265 years, -O-. 
HOSPITAL ADMISSIONS 
Figure 4 shows the trend in hospital admissions for 
asthma by age group when the rate in 1980 is set to 
100. A significant decrease in the rates in all age 
groups was observed, except for the significant 
increase in the O-4 years age group. Likewise, Fig. 5 
shows the data for COPD, where the trend in the 04 
and 265 years age groups showed a significant 
increase. In Table 2, the results of the time trend 
analyses illustrated in Figs 4 and 5 are presented, plus 
those for males and females separately. It is noted 
that in the age group 35-64 years, the trends for 
COPD in males and females are opposite. 
In Fig. 6, hospital admission rates are presented for 
acute bronchi(oli)tis in males and females in the 
youngest two age groups. In the 04 years age group, 
there was a considerable, significant increase in hos- 
pital admission rate in both males and females. In the 
age group 5-34 years, a slightly increasing trend was 
found in females, that proved to be significant, but 
the increase occurred mainly at the start of the period 
under study. 
Discussion 
Two main findings of this analysis with respect to 
asthma are the continuous increase in hospital admis- 
sions in the O-4 years age group and the large decline 
in mortality in the 265 years age group in the 1990s. 
In a previous study on childhood asthma in the 
Netherlands over the period 1980-87, it was found 
that hospital admission rates rose significantly in the 
04 years age group in both sexes (15). It is now seen 
that in the O-4 years age group, hospital admissions 
for asthma continued to increase even further in the 
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TABLE 2. Trend in hospital admissions for asthma and chronic obstructive pulmonary 
disease (COPD) by age group and gender in the period 1980-94 
Rate per lo6 









































+ 73.0 7.8 ~0~001 
- 9.8 1.1 <O.OOl 
- 29.3 1.3 ~0~001 





2 811 + 102.5 11 ~0~001 
188 - 13.2 l-2 -=O.OOl 
181 - 29.7 1.4 ~0~001 





1 361 +42.1 7.9 ~0~001 
294 - 6.2 1.1 ~0~001 
297 - 28.7 1.7 co.001 
340 - 31.8 2.8 ~0~001 
1289 1692 + 40.7 7.6 <O*OOl 
134 136 +0.4 0.6 0.520 
893 961 +4.6 3.2 0.171 
3814 6693 +201*6 18 <0~001 
1600 2198 + 58.4 9.7 
132 128 - 0.5 0.8 
1196 996 - 15.5 4.2 
6830 10 982 + 283.5 36 
963 1162 +22.1 5.7 
135 145 +1*3 0.6 
591 926 + 24.6 2.7 









*Code 493 and tCode 490, 491, 492, and 496, International Classification of Diseases 
(ICD-9). 
1990s. This increase is in contrast with the steady 
decrease in the other age groups. It is noted that the 
increase in hospital admissions occurred not only for 
asthma, but also for COPD and acute bronchi(oli)tis, 
especially in the second half of the study period. 
Males and females showed similar trends, with rates 
in males being higher, illustrating the predisposition 
for wheezing disorders in male infants. No data are 
available on first or repeat admissions, and thus no 
information can be obtained into what role asthma 
prevalence, asthma severity or change in management 
will have played. However, the worrying development 
of increasing hospital admissions for respiratory dis- 
eases in the O-4-year-olds had no impact on mor- 
tality; asthma and COPD mortality showed no trend, 
whereas mortality from acute bronchi(oli)tis fell. 
Thus, there is no indication of an increased mortality 
from asthma being masked. 
It is also noted that there appears to be no cohort 
effect of the O-4 years age group affecting the 5-34 
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FIG. 5. Hospital admissions for chronic obstructive 
pulmonary disease (ICD 490-2, 496) by age group 
in the period 1980-94, rates per million population 
in 1980= 100. Age group O-4 years, -0-; 5-34 
years, -a; 35-64 years, -O-; 265 years -0-. 
years age group. In this age group, decreasing admis- 
sion rates for asthma were found, while data on 
admissions for COPD showed no counteracting 
trend. Admissions for acute bronchi(oli)tis increased 
only in the early 1980s and thereafter remained 
rather stable, the level being much lower than that for 
asthma. Neither was there an indication for a cohort 
effect when the 5-9 years age subgroup was taken 
into consideration. In this subgroup, a significantly 
decreasing trend in hospital admissions for asthma 
occurred in both sexes (data not presented), despite 
the initial increase observed in males in the period 
1980-87 (15). An explanation might be that once 
asthma is being diagnosed, more adequate treatment 
is being instituted in the ambulatory health care. On 
E 
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FIG. 6. Hospital admissions for acute bronchi(oli)tis 
(ICD 466) in age groups 04 and 5-34 years by 
gender in the period 1980-94. Age group 04 years, 
-+-; 5-34 years, -A-; males, -; females, - - -. 
Males 04 years, slope (SE) + 160.2 (35); females 
O-4 years, slope (SE) + 115.3 (26) both WO.001; 
males 5-34 years, slope (SE) +0.3 (0.4) P=O.526; 
females 5-34 years, slope (SE) +0*6 (0.3), PzO.047. 
the other hand, infants make up a vulnerable group 
for wheezing disorders which seems to dilute at older 
ages in childhood (16,17). 
In the age group 2 65 years, mortality from asthma 
showed a large decline in the 1990s. Possible expla- 
nations for this trend can be better management, 
beneficial effects of prescribing anti-inflammatory 
drugs more frequently in the 2 65 years age group, or 
a labelling shift with a preference for COPD diagno- 
sis. From middle age, there will be an increasing 
influence of e.g. smoking, occupation and pollution 
on the respiratory system, leading to a more difficult 
distinction between asthma and COPD, particularly 
in the elderly. In comparison to the actual number of 
deaths from COPD, the number of deaths from 
asthma was very low, especially in the 2 65 years age 
group, notwithstanding the fact that 60-80% of 
asthma deaths in the 1980s occurred in this age 
group; e.g. in 1980, 125 deaths from asthma of a total 
of 202 occurred in the age group 2 65 years, whilst in 
1994, these figures were 15 of a total of 54. The 
decrease in mortality from asthma seen in the age 
group 35-64 years also occurred mainly at the end of 
the study period, both in males and females, although 
on a much smaller scale. In this age group, however, 
mortality from COPD showed discrepant trends 
between males (decrease in the second half of the 
study period) and females (slight increase). In the age 
groups 35-64 and > 65 years, the hospital admissions 
trends in males and females corresponded with the 
mortality trends. The observed trends in COPD mor- 
tality were similar to trends in mortality from chronic 
obstructive airways disease in several other countries, 
following the pattern of exposure to cigarette smoke 
(l&19). Chronic obstructive pulmonary disease 
presents a growing cause for concern, as highlighted 
by the recent consensus statement of the European 
Respiratory Society (20). However, a labelling shift 
from asthma to COPD might have contributed to the 
trends found, but in the age group 35-64 years, the 
discrepant trends between males and females and 
the magnitude of the slopes suggest that other factors 
have also played a role in the asthma trends. 
Asthma mortality in the age group 5-34 years 
concerned small numbers, and the rate fluctuated but 
declined significantly over the study period from an 
already relatively low level in the 1980s (4). There 
were no reciprocal trends in mortality from the other 
respiratory diseases studied, of which rates were also 
very low, making a change in coding practices or 
labelling unlikely (11). 
In conclusion, asthma management in the 
Netherlands seems to have improved as judged by the 
presented vital statistics, to which the guidelines 
might have been a contributing factor. However, in 
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the age group O-4 years, the continuous increase in 
hospital admissions for asthma as well as for the 
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